Chronic constipation and gut microbiota: current research insights and therapeutic implications DOI
Xiaoqian Xu, Yali Wang,

Yiyan Long

et al.

Postgraduate Medical Journal, Journal Year: 2024, Volume and Issue: unknown

Published: Aug. 16, 2024

Abstract Chronic constipation is a prevalent clinical condition. Its etiology and pathogenesis have not yet been fully understood. In recent years, mounting evidence suggests close association between chronic intestinal dysbiosis, including alterations in the colony structure metabolites, as well modulation of bowel movements via brain–gut–microbiota axis. With deepening related research, probiotic-related therapies are expected to become potential first-line treatment for future. this review, we summarize current research insights into intricate relationships gut microbiota briefly discuss several different approaches treating constipation. The findings from review may advance our understanding pathological mechanisms underlying and, ultimately, translate them improvements patient care.

Language: Английский

Bile Acids and Microbiota Interplay in Pancreatic Cancer DOI Open Access
Pratibha Malhotra,

Ranjith Palanisamy,

José A. Caparrós‐Martín

et al.

Cancers, Journal Year: 2023, Volume and Issue: 15(14), P. 3573 - 3573

Published: July 11, 2023

Evidence suggests the involvement of microbiota, including oral, intra-tumoral and gut, in pancreatic cancer progression response to therapy. The gut microbiota modulates bile acid pool is associated with maintaining host physiology. Studies have shown that acid/gut axis dysregulated cancer. Bile receptor expression levels are as well. also acids can cause cell injury facilitate proliferation. its metabolites, acids, altered other conditions considered risk factors for development alter responses chemotherapeutic treatments, thus affecting patient outcomes. Altogether, these findings suggest microbial and/or profiles could serve biomarkers detection. This review will discuss current knowledge on interaction between metabolism

Language: Английский

Citations

11

Balancing Act: Exploring the Gut Microbiota-Brown Adipose Tissue Axis in PCOS Pathogenesis and Therapeutic Frontiers DOI Creative Commons
Yanhui Li,

Yuqing Fang,

Hongbo Wang

et al.

Frontiers in Bioscience-Landmark, Journal Year: 2024, Volume and Issue: 29(6)

Published: May 30, 2024

Polycystic ovary syndrome (PCOS) is a prevalent reproductive, endocrine, and metabolic disease that affects 5–18% of women worldwide, with rising incidence. Hyperandrogenemia insulin resistance are two key pathophysiological factors contribute to PCOS, both which variety health issues such as menstrual irregularities, obesity, dysfunctional glucose lipid homeostasis, infertility, mental disorders, cardiovascular cerebrovascular diseases. Despite ongoing studies, the origin pathogenesis PCOS remain elusive; there also clinical need for simpler, more effective, longer lasting, comprehensive treatments PCOS. The gut–fat axis, critical regulatory route metabolism, endocrine function, immune response, has received considerable interest in recent years research etiology treatment illnesses type 2 diabetes mellitus non-alcoholic fatty liver disease. latest revealed significant alterations homogeneity phylogenetic diversity gut microbiota. Animal using fecal microbiota transplantation confirmed importance regulating sensitivity sex hormone balance Furthermore, studies have shown decrease volume and/or activity brown adipose tissue (BAT) patients, change alters adipokine release, leading hyperandrogenemia, aggravating progression. Given function BAT increasing energy expenditure alleviating parameters, efforts activate or induce browning white emerged possible Recent suggested can influence creation via metabolites short-chain acids bile acids, well gut–brain axis. Cold exposure, healthy dieting, metformin, bariatric surgery, glucagon-like peptide 1 receptor agonists melatonin all been basic modulate by influencing microbiota, demonstrating potential. However, into regulation mechanisms gut–BAT axis required produce comfortable, safe tailored therapeutics

Language: Английский

Citations

4

Bile Acids in Pancreatic Carcinogenesis DOI Creative Commons
Bharti Sharma,

Kate Twelker,

Cecilia Nguyen

et al.

Metabolites, Journal Year: 2024, Volume and Issue: 14(7), P. 348 - 348

Published: June 21, 2024

Pancreatic cancer (PC) is a dangerous digestive tract tumor that becoming increasingly common and fatal. The most form of PC pancreatic ductal adenocarcinoma (PDAC). Bile acids (BAs) are closely linked to the growth progression PC. They can change intestinal flora, increasing permeability allowing gut microbes enter bloodstream, leading chronic inflammation. High dietary lipids increase BA secretion into duodenum fecal levels. BAs cause genetic mutations, mitochondrial dysfunction, abnormal activation intracellular trypsin, cytoskeletal damage, NF-κB, acute pancreatitis, cell injury, necrosis. act on different types cells receptors, altering Ca

Language: Английский

Citations

4

Metabolic interactions of host-gut microbiota: New possibilities for the precise diagnosis and therapeutic discovery of gastrointestinal cancer in the future—A review DOI Creative Commons
Jianing Yu, Lu Li, Xufeng Tao

et al.

Critical Reviews in Oncology/Hematology, Journal Year: 2024, Volume and Issue: 203, P. 104480 - 104480

Published: Aug. 22, 2024

Gastrointestinal (GI) cancer continues to pose a significant global health challenge. Recent advances in our understanding of the complex relationship between host and gut microbiota have shed light on critical role metabolic interactions pathogenesis progression GI cancer. In this study, we examined how interact with influence signalling pathways that impact formation tumours. Additionally, investigated potential therapeutic approach manipulating for use clinical settings. Revealing molecular exchanges facilitates deeper underlying mechanisms drive development. Metabolic hold promise identification microbial signatures or associated specific stages Hence, study provides strategies diagnosis, treatment management cancers improve patient outcomes.

Language: Английский

Citations

4

Chronic constipation and gut microbiota: current research insights and therapeutic implications DOI
Xiaoqian Xu, Yali Wang,

Yiyan Long

et al.

Postgraduate Medical Journal, Journal Year: 2024, Volume and Issue: unknown

Published: Aug. 16, 2024

Abstract Chronic constipation is a prevalent clinical condition. Its etiology and pathogenesis have not yet been fully understood. In recent years, mounting evidence suggests close association between chronic intestinal dysbiosis, including alterations in the colony structure metabolites, as well modulation of bowel movements via brain–gut–microbiota axis. With deepening related research, probiotic-related therapies are expected to become potential first-line treatment for future. this review, we summarize current research insights into intricate relationships gut microbiota briefly discuss several different approaches treating constipation. The findings from review may advance our understanding pathological mechanisms underlying and, ultimately, translate them improvements patient care.

Language: Английский

Citations

4